XUE Liqiong, X. T. (2025). Expert consensus on the combination of anti-EGFR monoclonal antibodies and immune checkpoint inhibitors in the treatment of head and neck squamous cell carcinoma (2025 edition). Editorial Office of China Oncology.
Chicago Style (17th ed.) CitationXUE Liqiong, XU Tingting. Expert Consensus on the Combination of Anti-EGFR Monoclonal Antibodies and Immune Checkpoint Inhibitors in the Treatment of Head and Neck Squamous Cell Carcinoma (2025 Edition). Editorial Office of China Oncology, 2025.
MLA (9th ed.) CitationXUE Liqiong, XU Tingting. Expert Consensus on the Combination of Anti-EGFR Monoclonal Antibodies and Immune Checkpoint Inhibitors in the Treatment of Head and Neck Squamous Cell Carcinoma (2025 Edition). Editorial Office of China Oncology, 2025.